Search Results 281-290 of 16394 for infliximab

  1. Tildrakizumab-asmn (subcutaneous route) - Side effects & uses - Mayo Clinic

    Tildrakizumab-asmn injection is used to treat moderate to severe plaque psoriasis, which is a skin disease with red patches and white scales that do not go away ...

  2. Tocilizumab-bavi (intravenous route) - Side effects & uses - Mayo Clinic

    Tocilizumab-bavi injection is also used with a tapering course of glucocorticoids (steroid medicine) to treat giant cell arteritis (inflammation of the arteries) ...

  3. Margetuximab-cmkb (intravenous route) - Side effects & uses - Mayo Clinic

    Margetuximab-cmkb injection is used to treat metastatic (cancer that has spread) HER2-positive breast cancer in patients who have received two or more anti-HER2 ...

  4. Targeted Drug Therapy Clinical Trials - Mayo Clinic Research

    Among persons with Immunoglobulin G subclass 4 Related Disease (IgG4)-related disease who have persistent or recurrent disease despite standard therapies, does ...

  5. Rubella and mumps virus vaccine live (intramuscular route) - Side effects & dosage - Mayo Clinic

    Infliximab; Influenza Virus Vaccine, Live; Ixekizumab; Lebrikizumab-lbkz. Show More. Receiving this vaccine with any of the following medicines may cause an ...

  6. Expanded Access to Cyclic Irrigation in Patients Undergoing Exchange Arthroplasty - Mayo Clinic

    ... Infliximab (Remicade) Ustekinumab (Stelara) Abatacept (Orencia) Tofacitinib (Xeljanz) Belimumab (Benlysta). Note: Other protocol defined Inclusion/Exclusion ...

  7. Measles virus vaccine, live (subcutaneous route) - Side effects & dosage - Mayo Clinic

    Infliximab; Influenza Virus Vaccine, Live; Ixekizumab; Lebrikizumab-lbkz. Show More. Receiving this vaccine with any of the following medicines may cause an ...

  8. An Efficacy and Safety Study Of Pracinostat In Combination With Azacitidine In Adults With Acute Myeloid Leukemia - Mayo Clinic

    ... infliximab, rituximab, ethotrexate, or similar). Class III obesity defined as a Body Mass Index (BMI) > 40 kg/m2. Renal impairment defined as serum ...

  9. Multiple Myeloma Clinical Trials - Mayo Clinic Research

    The primary objectgive of this study is to determine the effectiveness of SAR442168 compared to placebo in delaying disability progression in primary ...

  10. A Study to Test the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) with One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors - Mayo Clinic

    Giving cabozantinib, nivolumab, and ipilimumab may work better in treating patients with genitourinary tumors that have no treatment options compared to giving ...